A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Non-Small Cell Lung Carcinoma|Breast Cancer|Melanoma|Upper GI Tract Carcinoma|Colon Carcinoma|Renal Cell Carcinoma|Bladder Carcinoma|Prostate Cancer
Interventions: BIOLOGICAL: V935|BIOLOGICAL: V934-EP
Sponsor: Merck Sharp & Dohme LLC